121 related articles for article (PubMed ID: 8379924)
1. Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme.
Williams CH; Yamamoto T; Walsh DM; Allsop D
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):681-4. PubMed ID: 8379924
[TBL] [Abstract][Full Text] [Related]
2. Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme.
Cardozo C; Orlowski M
Peptides; 1993; 14(6):1259-62. PubMed ID: 8134308
[TBL] [Abstract][Full Text] [Related]
3. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
[TBL] [Abstract][Full Text] [Related]
4. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
[TBL] [Abstract][Full Text] [Related]
5. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.
Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG
Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate.
Chappell MC; Welches WR; Brosnihan KB; Ferrario CM
Peptides; 1992; 13(5):943-6. PubMed ID: 1336190
[TBL] [Abstract][Full Text] [Related]
7. Effects of a metalloendopeptidase-24.15. Inhibitor on renal hemodynamics and function in rats.
Yang XP; Saitoh S; Scicli AG; Mascha E; Orlowski M; Carretero OA
Hypertension; 1994 Jan; 23(1 Suppl):I235-9. PubMed ID: 8282366
[TBL] [Abstract][Full Text] [Related]
8. A novel synthetic inhibitor of endopeptidase-24.15.
Ukai Y; Li Q; Ito S; Mita S
J Enzyme Inhib; 1996 Aug; 11(1):39-49. PubMed ID: 9204395
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid.
Barelli H; Dive V; Yiotakis A; Vincent JP; Checler F
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):621-5. PubMed ID: 1332678
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone.
Lasdun A; Reznik S; Molineaux CJ; Orlowski M
J Pharmacol Exp Ther; 1989 Nov; 251(2):439-47. PubMed ID: 2681686
[TBL] [Abstract][Full Text] [Related]
11. Endopeptidase 24.15 modulates bradykinin-induced contraction in guinea-pig trachea.
Da Silva A; Dhuy J; Waeldelé F; Bertrand C; Landry Y
Eur J Pharmacol; 1992 Feb; 212(1):97-9. PubMed ID: 1372868
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins.
Molineaux CJ; Ayala JM
J Neurochem; 1990 Aug; 55(2):611-8. PubMed ID: 1973455
[TBL] [Abstract][Full Text] [Related]
13. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.
Bull HG; Thornberry NA; Cordes MH; Patchett AA; Cordes EH
J Biol Chem; 1985 Mar; 260(5):2952-62. PubMed ID: 2982845
[TBL] [Abstract][Full Text] [Related]
15. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
[TBL] [Abstract][Full Text] [Related]
16. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes.
Anastasopoulos F; Leung R; Kladis A; James GM; Briscoe TA; Gorski TP; Campbell DJ
J Pharmacol Exp Ther; 1998 Mar; 284(3):799-805. PubMed ID: 9495836
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiotensin converting enzyme: dependence on chloride.
Shapiro R; Riordan JF
Biochemistry; 1984 Oct; 23(22):5234-40. PubMed ID: 6095894
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive properties of inhibitors of endopeptidase 24.15.
Kest B; Orlowski M; Molineaux CJ; Bodnar RJ
Int J Neurosci; 1991; 56(1-4):141-9. PubMed ID: 1938129
[TBL] [Abstract][Full Text] [Related]
19. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.
Robl JA; Cimarusti MP; Simpkins LM; Brown B; Ryono DE; Bird JE; Asaad MM; Schaeffer TR; Trippodo NC
J Med Chem; 1996 Jan; 39(2):494-502. PubMed ID: 8558518
[TBL] [Abstract][Full Text] [Related]
20. Uptake of N-[1 (S)-carboxy-(4-OH-3-125I-phenyl)ethyl]-L-Ala-L-Pro, an inhibitor of angiotensin-converting enzyme by rabbit lungs in situ.
Turrin M; Pitt BR; Ryan JW; Chung AY; Clark MB; Gillis CN
J Pharmacol Exp Ther; 1986 Jul; 238(1):14-8. PubMed ID: 3014113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
